Practice Support Update Blog

FDA approves Narcan 4mg nasal spray for OTC use

Apr 4, 2023 8:00:00 AM / by Practice Support Team

On March 29, the FDA approved the first nonprescription, 'over-the-counter' (OTC) naloxone nasal spray, Narcan. Naloxone--a medicine that can reverse an opioid-related overdose--has been shown to be a critical tool to prevent fatal overdoses, connect more people to treatment for substance use disorder, and save lives. 


This action by the Biden-Harris administration to make this naloxone product available without a prescription will pave the way for the life-saving medication to be sold directly to consumers in places like drug stores, convenience stores, grocery stores and gas stations, as well as online.

In addition to being used by health care professionals, naloxone is increasingly being distributed to first responders, and family members who may witness and respond to an opioid overdose. The availability of nonprescription and prescription naloxone could help to further increase its distribution and accessibility, potentially saving more lives and reducing the burden of overdose on individuals, families, and communities.

(source: press release )

(image source - no alterations to original made- photo )


Tags: overdose, opioid use disorder

  • There are no suggestions because the search field is empty.

Practice Support Services

Health care practices in North Carolina face many challenges. Our team of quality improvement coaches (QICs) have skills and expertise to support you in your transformation efforts.

To learn more about Practice Support Click Here

Apply for practice support services - fill out an application here

Subscribe to Blog Updates

Additional Resources:
Tip Sheets
Lib Guides
Interactive Resource Guides
Digital Library
New call-to-action
Join email list

Connect With Us:

Posts by Topic

See all

In Case You Missed It... Check Out These Recent Posts